| Dr Alan Larkin, DMD, MS | |
|
10645 Double R Blvd, Reno, NV 89521-8920 | |
| (775) 852-6164 | |
| Not Available |
| Full Name | Dr Alan Larkin |
|---|---|
| Gender | Male |
| Speciality | Dentist - Orthodontics And Dentofacial Orthopedics |
| Location | 10645 Double R Blvd, Reno, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083957138 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223X0400X | Dentist - Orthodontics And Dentofacial Orthopedics | S3-244 (Nevada) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alan Larkin, DMD, MS 10645 Double R Blvd, Reno, NV 89521-8920 Ph: (775) 852-6164 | Dr Alan Larkin, DMD, MS 10645 Double R Blvd, Reno, NV 89521-8920 Ph: (775) 852-6164 |
News Archive
Rivaroxaban has been found to be effective in the prevention of venous thromboembolism (VTE) after orthopedic surgery, for the prevention of stroke in AF (Atrial fibrillation) patients, and as additional therapy to conventional antiplatelet therapy in ACS (Acute coronary syndrome) patients.
The U.S. Food and Drug Administration has approved the first generic version of Effexor (venlafaxine), an important step in the agency's effort to increase the availability of lower-cost generic medications.
As part of its "Blueprint" series discussing the creation of a U.S. global AIDS blueprint called for by Secretary of State Hillary Clinton in July, the Center for Global Health Policy's "Science Speaks" blog features a guest post by Allan Clear, executive director of the Harm Reduction Coalition, in which he highlights an existing "WHO, UNODC, UNAIDS Technical Guide [.pdf] for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users."
Pharmasset, Inc. today announces the initiation of a 28-day Phase 2a study with PSI-7977, a chirally pure isomer form of PSI-7851, a nucleotide analog polymerase inhibitor in development for the treatment of chronic hepatitis C (HCV). The trial will evaluate various doses of PSI-7977 in combination with Pegasys (peginterferon alfa 2a) and Copegus (ribavirin) in patients with HCV genotype 1 who have not been treated previously.
› Verified 7 days ago
Gerald M York, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 855 W 7th St, Suite #5, Reno, NV 89503 Phone: 775-322-5016 Fax: 775-329-0510 | |
Dr. Peggy D. Preston, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 3502 S Virginia St, Suite A4, Reno, NV 89502 Phone: 775-827-8808 Fax: 775-827-9297 | |
Dr. Nicole Michelle Stoker, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 3701 Baker Ln Ste 1, Reno, NV 89509 Phone: 775-825-1000 Fax: 775-826-3030 | |
Megan Archer, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 10595 Double R Blvd, Reno, NV 89521 Phone: 775-825-8463 | |
Monica Tricia Lee, DDS Dentist Medicare: Medicare Enrolled Practice Location: 6350 Mae Anne Ave, Ste #1, Reno, NV 89523 Phone: 775-787-2600 | |
Dr. Jason L Sala, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 4875 Summit Ridge Drive, Reno, NV 89523 Phone: 775-322-2061 Fax: 775-322-2065 | |
Dr. Derek Lyle Johnson, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 175 Brinkby Ave, Reno, NV 89509 Phone: 775-825-9225 |